Find your next paid study

Northwestern UniversityNCT06571734

~$75 – $2,000

Actual pay is set by the research site.

Soft Tissue SarcomaStage I Soft Tissue Sarcoma of the Trunk and ExtremitiesStage II Soft Tissue Sarcoma of the Trunk and Extremities+1 more

Pre-Operative ERAS® (Enhanced Recovery After Surgery): Randomized Feasibility Trial of Implementing Individualized Prehabilitation for People Undergoing Neo-Adjuvant Radiotherapy and Lower Limb Soft-Tissue Sarcoma Surgery

This clinical trial evaluates whether patients with deep soft tissue sarcomas who receive a tailored prehabilitation exercise regimen during standard radiother…

Phase 2ZanzalintinibPembrolizumab+2 more

Actual pay is set by the research site.

Mayo ClinicNCT05526417

Phase 2

Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma

To learn if zanzalintinib and pembrolizumab can help to control select subtypes of advanced/metastatic soft-tissue sarcoma (UPS, MFS, HGPS, and HGUS

M.D. Anderson Cancer CenterNCT07283731

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

A Multi-cohort Study of Retifanlimab With or Without Gemcitabine and Docetaxel in Patients With Advanced Sarcoma

This study is being done to find out whether the study drug Retifanlimab, a monoclonal antibody against the PD-1 protein, combined with gemcitabine and docetax…

Soft Tissue SarcomaSarcoma,Soft TissueSarcoma+1 more

Memorial Sloan Kettering Cancer CenterNCT04577014

~$150 – $3,000

Actual pay is set by the research site.

Phase 3

A Phase 3 Open-label Extension (OLE) Study to Evaluate the Long-term Safety and Efficacy of Ralinepag in Subjects With World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension (PAH)

Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Phase 2 or P…

PAHPulmonary HypertensionPulmonary Arterial Hypertension+8 more

United TherapeuticsNCT03683186

~$50 – $2,100

Actual pay is set by the research site.

Tissue Expander Based Breast Reconstruction

A Prospective Randomized Trial of Local Antibiotic Carriers in Tissue Expander-Based Breast Reconstruction

Infections after tissue expander breast reconstruction can lead to pain, additional surgeries, and loss of the reconstruction. This study will compare two type…

University of California, DavisNCT07339215

Actual pay is set by the research site.

Phase 4

Comparing Two Durations of Antibiotic Treatment for Children Hospitalized With Common Infections

Infections like pneumonia, skin and soft tissue infection (also called SSTI or cellulitis), and urinary tract infections (UTI) are some of the most common reas…

PneumoniaSkin and Soft Tissue (SST) InfectionUrinary Tract Infections (UTIs)

University of California, San FranciscoNCT07322146

~$25 – $900

Actual pay is set by the research site.

Phase 2

MOZART MZL: A Randomized Phase II Study Evaluating Mosunetuzumab Alone and in Combination With Either Zanubrutinib or Polatuzumab Vedotin for the Treatment of Patients With Relapsed/Refractory Marginal Zone Lymphoma

This phase II trial compares the effect of mosunetuzumab alone to mosunetuzumab with zanubrutinib or polatuzumab vedotin in patients with marginal zone lymphom…

Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueRecurrent Nodal Marginal Zone LymphomaRecurrent Splenic Marginal Zone Lymphoma+3 more

~$75 – $3,000

Actual pay is set by the research site.

Sleeve GastrectomyCholecystectomySplenectomy+16 more

Stanford Program to Accelerate Robotic Children's Surgery

The goal of this clinical trial is to provide additional data to confirm safety and performance of the da Vinci Xi Surgical System in a human clinical setting.…

Stanford UniversityNCT06671639

Actual pay is set by the research site.

ATHN Transcends: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment in People With Non-Neoplastic Hematologic Disorders

In parallel with the growth of ATHN's clinical studies, the number of new therapies for all blood disorders is increasing significantly. Some of the recently F…

Hematologic DisorderBleeding DisorderConnective Tissue Disorder+10 more

American Thrombosis and Hemostasis NetworkNCT04398628

~$10 – $1,125

Actual pay is set by the research site.

Tissue ExpansionImplant Based Breast Reconstruction

Blossom® Smart Expander Device for Tissue Expander/Implant-Based Breast Reconstruction

The conventional breast tissue expander used for breast reconstruction/ augmentation requires weekly or biweekly injections of saline through the skin and into…

Stanford UniversityNCT05975372

Actual pay is set by the research site.

Phase 2

A Phase II Study of the Non-Covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab in Patients With Marginal Zone Lymphoma

This phase II trial tests the effect of nemtabrutinib in combination with rituximab in treating patients with marginal zone lymphoma. Nemtabrutinib, a non-cova…

Conjunctival Mucosa-Associated Lymphoid Tissue LymphomaGastric Mucosa-Associated Lymphoid Tissue LymphomaMarginal Zone Lymphoma+4 more